Use of Lanreotide LAR in the Case of Intolerance of Octreotide LAR in Patients Well-differentiated NETs
#1338
Introduction: Intolerance of Octreotide is about 10 % of cases
Aim(s): To evaluate the tolerability of Lanreotide LAR in the case of intolerance of Octreotide LAR
Materials and methods: 5 patients with metastatic well-differentiated (G1-G2) functioning EP-NETs (2 – pancreas, 1 – cecum, 2 – small intestine).
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author:
Authors: Gorbunova V, Orel N, Emelianova G, Kuzminov A, Markovich A,
Keywords: Octreotide, Lanreotide, intolerance, NETs,
To read the full abstract, please log into your ENETS Member account.